Swartz Harold M, Iwasaki Akinori, Walczak Tadeusz, Demidenko Eugene, Salikov Ildar, Lesniewski Piotr, Starewicz Piotr, Schauer David, Romanyukha Alex
Dartmouth Medical School, EPR Center for Viable Systems, Hanover, NH 03755, USA.
Appl Radiat Isot. 2005 Feb;62(2):293-9. doi: 10.1016/j.apradiso.2004.08.016.
There are plausible circumstances in which populations potentially have been exposed to doses of ionizing radiation that could cause direct clinical effects within days or weeks, but there is no clear knowledge as to the magnitude of the exposure to individuals. In vivo EPR is a method, perhaps the only such method that can differentiate among doses sufficiently to classify individuals into categories for treatment with sufficient accuracy to facilitate decisions on medical treatment. Individuals with significant risk then can have appropriate procedures initiated immediately, while those without a significant probability of acute effects could be reassured and removed from the need for further medical treatment. In its current state, the in vivo EPR dosimeter can provide estimates of absorbed dose of +/-25 cGy in the range of 100-->1000 cGy. This is expected to improve, with improvements in the resonator, the algorithm for calculating dose, and the uniformity of the magnetic field. In its current state of development, it probably is sufficient for most applications related to terrorism or nuclear warfare, for decision-making for action for individuals in regard to acute effects from exposure to ionizing radiation.
在某些看似合理的情况下,人群可能已暴露于一定剂量的电离辐射,这些辐射剂量可能在数天或数周内导致直接的临床效应,但对于个体所受辐射剂量的大小却尚无明确了解。体内电子顺磁共振(EPR)是一种方法,或许是唯一一种能够充分区分不同剂量,从而以足够的准确性将个体分类以便进行治疗,进而有助于做出医疗决策的方法。具有重大风险的个体随后可立即启动适当的程序,而那些不太可能产生急性效应的个体则可得到安抚,并无需进一步接受治疗。就目前而言,体内EPR剂量计在100至1000 cGy的范围内能够提供±25 cGy的吸收剂量估计值。随着谐振器、剂量计算算法以及磁场均匀性的改进,预计这一情况将会得到改善。就其目前的发展状态而言,对于大多数与恐怖主义或核战争相关的应用,以及针对个体因暴露于电离辐射而产生急性效应的行动决策而言,它可能已经足够。